Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Kodiak Sciences Inc. (KOD)
Sector: Healthcare; Industry: Biotechnology

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat retinal diseases. Its preclinical stage product candidate include KSI-501, a bispecific anti-interleukin 6/VEGF bioconjugate to target inflammation and abnormal angiogenesis in the pathogenesis of retinal vascular diseases. The company's early research pipeline include KSI-601, a triplet inhibitor for dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015.

KOD Symbol Info by TradingView

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-03-22 EHRLICH JASON nan Sell 6,950 $131.50 $913,894 Yes
2021-03-10 BORGESON JOHN A. nan Sell 5,000 $130.08 $650,415 No
2021-02-22 EHRLICH JASON nan Sell 6,950 $125.81 $874,367 Yes
2021-01-20 EHRLICH JASON nan Sell 26,950 $162.77 $4,386,776 Yes
2020-12-23 EHRLICH JASON nan Sell 6,950 $144.55 $1,004,610 Yes
2020-11-20 EHRLICH JASON nan Sell 6,950 $138.79 $964,601 Yes
2020-11-20 BAKER BROS. ADVISORS LP 10%-Owner, Director Buy 1,527,777 $108.00 $164,999,916 No
2020-10-27 EHRLICH JASON nan Sell 7,500 $100.00 $750,000 Yes
2020-10-23 EHRLICH JASON nan Sell 7,500 $86.25 $646,875 Yes
2020-10-20 EHRLICH JASON nan Sell 6,950 $78.39 $544,817 Yes
2020-10-13 EHRLICH JASON nan Sell 5,000 $75.00 $375,000 Yes
2020-10-09 EHRLICH JASON nan Sell 2,200 $71.28 $156,819 Yes
2020-09-25 BAKER BROS. ADVISORS LP 10%-Owner, Director Buy 48,125 $56.65 $2,726,182 No
2020-09-24 BAKER BROS. ADVISORS LP 10%-Owner, Director Buy 203,047 $51.71 $10,498,591 No
2020-09-21 EHRLICH JASON nan Sell 6,950 $52.40 $364,182 Yes
2020-09-08 BAKER BROS. ADVISORS LP 10%-Owner, Director Buy 322,979 $47.43 $15,318,311 No
2020-08-20 EHRLICH JASON nan Sell 6,950 $47.11 $327,444 Yes
2020-08-21 BAKER BROS. ADVISORS LP 10%-Owner, Director Buy 203,486 $48.23 $9,815,002 No
2020-07-20 EHRLICH JASON nan Sell 6,950 $50.44 $350,526 Yes
2020-06-22 EHRLICH JASON nan Sell 6,950 $60.54 $420,747 Yes
2020-05-20 EHRLICH JASON See Remarks Sell 6,950 $60.72 $421,989 Yes
2020-04-20 EHRLICH JASON See Remarks Sell 6,950 $54.12 $376,115 Yes
2020-04-09 EHRLICH JASON See Remarks Sell 2,200 $48.56 $106,830 Yes
2020-04-02 Liang Hong SVP, Discovery Medicine Sell 4,000 $42.34 $169,360 No
2020-03-26 Liang Hong SVP, Discovery Medicine Sell 4,000 $47.78 $191,112 No
2020-03-20 Levy Richard S Director Buy 1,000 $44.33 $44,330 No
2020-03-20 EHRLICH JASON See Remarks Sell 6,950 $45.00 $312,762 Yes
2020-03-19 Liang Hong SVP, Discovery Medicine Sell 4,000 $39.45 $157,811 No
2020-03-18 BAKER BROS. ADVISORS LP 10%-Owner, Director Buy 150,000 $39.29 $5,893,804 No
2020-02-26 BAKER BROS. ADVISORS LP 10%-Owner, Director Buy 377,249 $57.87 $21,830,242 No

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.

Insider Smart

Ovintiv Inc (OVV) - Insiders of OVV have been HEAVILY accumulating shares in March with a sub-$3 cost. And the stock is now $11. An awesome 400% gain can't be missed if you found it was heavily accumulated earlier.